Blood Coagulation & Fibrinolysis

Papers
(The TQCC of Blood Coagulation & Fibrinolysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe75
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination24
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy20
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding18
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays17
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans12
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment11
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis11
Current epidemiology of deaths for disseminated intravascular coagulation11
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis10
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing10
Clot waveform analysis in hemophilia carriers9
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream9
Obesity and physical exercise in hemophilia9
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays9
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin8
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome8
Genetic and clinical characterization of factor VII deficiency: insights from 34 Turkish patients7
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab7
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency7
The procoagulant potential before and after surgery for endometriosis and its association with disease severity7
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes7
Disability and the social impact of hemophilia7
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant6
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy6
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease6
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis6
The physiology of hemostasis6
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report6
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus5
Endotoxemia-induced protein C surge protects mice against venous thrombosis based on transient lowering of natural anticoagulants5
Acquired Bernard–Soulier syndrome and hypodysfibrinogenaemia because of multiple myeloma5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India5
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population5
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients5
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics4
An alternative method to assess the long-term stability of frozen plasmas for coagulation testing4
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock4
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism4
Haploidentical stem cell transplantation in DOCK8 deficiency: a case report of successful outcomes4
Factor VIII beyond haemophilia: a hidden regulator of venous thrombosis and endothelial dysfunction4
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?4
Why do patients with antiphospholipid syndrome bleed? A clinical paradox4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis4
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency4
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies3
A rare case of essential thrombocythemia with pseudo-hyperkalemia3
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient3
Advances in nanotechnology for synthetic polymer hemostats: navigating precision hemostasis3
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians3
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations3
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays3
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays3
Hemolysis detection accuracy on Stago sthemO 3013
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities3
Harmonizing factor assay-related testing performed in a large laboratory network3
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests3
The factor V H1327R (rs1800595) polymorphism is associated with venous thromboembolic events: a case–control study in southern Iran3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment3
Association between thrombophilic gene variants and thrombosis in Iranian population: a systematic review and meta-analysis3
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease2
Sustained good response to rituximab in acquired von Willebrand syndrome2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major2
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event2
Interpreting coagulation mixing study results in the era of direct oral anticoagulants2
Serum levels of inflammatory markers, sP-selectin, IL-1β, IL-6, and hsCRP are positively correlated with tissue factor transcript level of peripheral blood mononuclear cells in stroke2
Psychological complications among patients with congenital bleeding disorders2
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage2
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score2
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study2
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII2
Management of autoimmune factor XIII deficiency in a frail, elderly patient2
Hemostatic cover in orthopedic surgery2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review2
Safety and efficacy of thrombolytic interventions in the treatment of intermediate and high-risk pulmonary embolism2
Disseminated intravascular coagulation in acute leukemia patients2
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding2
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases2
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation2
Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery2
A challenging case of heparin-induced skin necrosis without thrombocytopenia2
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study2
Measuring coagulopathy in pediatric craniofacial surgery2
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease2
Bleeding disorders in Saudi Arabia, causes and prevalence: a review2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism2
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations2
Thrombin generation assay: the present and the future2
Silent progression of hemophilic arthropathy of the elbow: case reports of three pediatric patients2
0.53234696388245